Table of Contents
Journal of Signal Transduction
Volume 2011, Article ID 179057, 9 pages
http://dx.doi.org/10.1155/2011/179057
Review Article

-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis: Role of 1 Integrins

Department of Physiology, James H Quillen Veterans Affairs Medical Center, James H Quillen College of Medicine, East Tennessee State University, P.O. Box 70576, Johnson City, TN 37614, USA

Received 2 December 2010; Revised 28 January 2011; Accepted 16 March 2011

Academic Editor: Terry Hebert

Copyright © 2011 Parthiv Amin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Garg, J. Narula, and Y. Chandrashekhar, “Apoptosis and heart failure: clinical relevance and therapeutic target,” Journal of Molecular and Cellular Cardiology, vol. 38, no. 1, pp. 73–79, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Kajstura, R. Bolli, E. H. Sonnenblick, P. Anversa, and A. Leri, “Cause of death: suicide,” Journal of Molecular and Cellular Cardiology, vol. 40, no. 4, pp. 425–437, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. I. J. Benjamin and M. D. Schneider, “Learning from failure: congestive heart failure in the postgenomic age,” Journal of Clinical Investigation, vol. 115, no. 3, pp. 495–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. S. Whelan, V. Kaplinskiy, and R. N. Kitsis, “Cell death in the pathogenesis of heart disease: mechanisms and significance,” Annual Review of Physiology, vol. 72, pp. 19–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. Hasking, M. D. Esler, and G. L. Jennings, “Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity,” Circulation, vol. 73, no. 4, pp. 615–621, 1986. View at Google Scholar
  6. M. R. Bristow, “β-adrenergic receptor blockade in chronic heart failure,” Circulation, vol. 101, no. 5, pp. 558–569, 2000. View at Google Scholar · View at Scopus
  7. K. Singh, L. Xiao, A. Remondino, D. B. Sawyer, and W. S. Colucci, “Adrenergic regulation of cardiac myocyte apoptosis,” Journal of Cellular Physiology, vol. 189, no. 3, pp. 257–265, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. D. F. Goldspink, J. G. Burniston, G. M. Ellison, W. A. Clark, and L. B. Tan, “Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways?” Experimental Physiology, vol. 89, no. 4, pp. 407–416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Krishnamurthy, V. Subramanian, M. Singh, and K. Singh, “β1 integrins modulate β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling,” Hypertension, vol. 49, no. 4, pp. 865–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. E. Ingber, “Cellular basis of mechanotransduction,” Biological Bulletin, vol. 194, no. 3, pp. 323–327, 1998. View at Google Scholar · View at Scopus
  11. D. G. Simpson, M. Majeski, T. K. Borg, and L. Terracio, “Regulation of cardiac myocyte protein turnover and myofibrillar structure in vitro by specific directions of stretch,” Circulation Research, vol. 85, no. 10, pp. e59–e69, 1999. View at Google Scholar · View at Scopus
  12. L. Terracio, A. Tingstrom, W. H. Peters III, and T. K. Borg, “A potential role for mechanical stimulation in cardiac development,” Annals of the New York Academy of Sciences, vol. 588, pp. 48–60, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Hadcock and C. C. Malbon, “Agonist regulation of gene expression of adrenergic receptors and G proteins,” Journal of Neurochemistry, vol. 60, no. 1, pp. 1–9, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. D. G. Rokosh, A. F. R. Stewart, K. C. Chang et al., “α1-adrenergic receptor subtype mRNAs are differentially regulated by α1-Adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo: repression of α1B and α1D but induction of α1C,” Journal of Biological Chemistry, vol. 271, no. 10, pp. 5839–5843, 1996. View at Google Scholar
  15. M. Böhm, I. Kouchi, P. Schnabel, and O. Zolk, “Transition from hypertrophy to failure-β-adrenergic desensitization of the heart,” Heart Failure Reviews, vol. 4, no. 4, pp. 329–351, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. B. G. Benfey, “Function of myocardial α-adrenoceptors,” Life Sciences, vol. 46, no. 11, pp. 734–757, 1990. View at Google Scholar · View at Scopus
  17. Y. Dakka, L. M. Luttrell, and R. J. Lefkowitz, “Switching of the coupling of the β-adrenergic receptor to different g proteins by protein kinase A,” Nature, vol. 390, no. 6655, pp. 88–91, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. R. P. Xiao, “Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins,” Science's STKE, vol. 2001, no. 104, article RE15, 2001. View at Google Scholar · View at Scopus
  19. V. O. Nikolaev, A. Moshkov, A. R. Lyon et al., “β-adrenergic receptor redistribution in heart failure changes cAMP compartmentation,” Science, vol. 327, no. 5973, pp. 1653–1657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Malinowska and E. Schlicker, “Mediation of the positive chronotropic effect of CGP12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors,” British Journal of Pharmacology, vol. 117, pp. 943–949, 1996. View at Google Scholar
  21. D. Sarsero, P. Molenaar, A. J. Kaumann, and N. S. Freestone, “Putative β-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[H]-CGP 12177 binding,” British Journal of Pharmacology, vol. 128, no. 7, pp. 1445–1460, 1999. View at Google Scholar · View at Scopus
  22. S. Moniotte, C. Belge, B. Sekkali et al., “Sepsis is associated with an upregulation of functional β3 adrenoceptors in the myocardium,” European Journal of Heart Failure, vol. 9, no. 12, pp. 1163–1171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Bundkirchen, K. Brixius, B. B. Olck, and R. H. G. Schwinger, “Bucindolol exerts agonistic activity on the propranolol-insensitive state of β-adrenoceptors in human myocardium,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 3, pp. 794–801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. J. G. Granneman, “The putative β-adrenergic receptor is a novel state of the β-adrenergic receptor,” American Journal of Physiology, vol. 280, no. 2, pp. E199–E202, 2001. View at Google Scholar · View at Scopus
  25. G. Rona, “Catecholamine cardiotoxicity,” Journal of Molecular and Cellular Cardiology, vol. 17, no. 4, pp. 291–306, 1985. View at Google Scholar · View at Scopus
  26. D. L. Mann, R. L. Kent, B. Parsons, and G. Cooper IIII, “Adrenergic effects on the biology of the adult mammalian cardiocyte,” Circulation, vol. 85, no. 2, pp. 790–804, 1992. View at Google Scholar · View at Scopus
  27. C. Communal, K. Singh, D. R. Pimentel, and W. S. Colucci, “Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway,” Circulation, vol. 98, no. 13, pp. 1329–1334, 1998. View at Google Scholar · View at Scopus
  28. Y. Shizukuda, P. M. Buttrick, D. L. Geenen, A. C. Borczuk, R. N. Kitsis, and E. H. Sonnenblick, “β-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy,” American Journal of Physiology, vol. 275, no. 3, pp. H961–H968, 1998. View at Google Scholar · View at Scopus
  29. E. Iwai-Kanai, K. Hasegawa, M. Araki, T. Kakita, T. Morimoto, and S. Sasayama, “α- and β-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes,” Circulation, vol. 100, no. 3, pp. 305–311, 1999. View at Google Scholar
  30. K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.-S. Liang, “Importance of antioxidant and antiapoptotic effects of β-receptor blockers in heart failure therapy,” American Journal of Physiology, vol. 287, no. 3 56-3, pp. H1003–H1012, 2004. View at Publisher · View at Google Scholar
  31. I. Ahmet, M. Krawczyk, W. Zhu et al., “Cardioprotective and survival benefits of long-term combined therapy with β adrenoreceptor (AR) agonist and β AR blocker in dilated cardiomyopathy postmyocardial infarction,” Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 2, pp. 491–499, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Shizukuda and P. M. Buttrick, “Subtype specific roles of β-adrenergic receptors in apoptosis of adult rat ventricular myocytes,” Journal of Molecular and Cellular Cardiology, vol. 34, no. 7, pp. 823–831, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Communal, K. Singh, D. B. Sawyer, and W. S. Colucci, “Opposing effects of β- and β-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein,” Circulation, vol. 100, no. 22, pp. 2210–2212, 1999. View at Google Scholar · View at Scopus
  34. S. Engelhardt, L. Hein, F. Wiesmann, and M. J. Lohse, “Progressive hypertrophy and heart failure in β-adrenergic receptor transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 12, pp. 7059–7064, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. J. D. Bisognano, H. D. Weinberger, T. J. Bohlmeyer et al., “Myocardial-directed overexpression of the human β-adrenergic receptor in transgenic mice,” Journal of Molecular and Cellular Cardiology, vol. 32, no. 5, pp. 817–830, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. C. A. Milano, L. F. Allen, P. C. Dolber et al., “Marked enhancement in myocardial function resulting from overexpression of a human β-adrenergic receptor gene,” Journal of Thoracic and Cardiovascular Surgery, vol. 109, no. 2, pp. 236–241, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. H. A. Rockman, R. Hamilton, L. R. Jones, C. A. Milano, L. Mao, and R. J. Lefkowitz, “Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the β-adrenergic receptor is associated with reduced phospholamban protein,” Journal of Clinical Investigation, vol. 97, no. 7, pp. 1618–1623, 1996. View at Google Scholar · View at Scopus
  38. H. B. Bittner, E. P. Chen, C. A. Milano, R. J. Lefkowitz, and P. Van Trigt, “Functional analysis of myocardial performance in murine hearts overexpressing the human β2-adrenergic receptor,” Journal of Molecular and Cellular Cardiology, vol. 29, no. 3, pp. 961–967, 1997. View at Publisher · View at Google Scholar
  39. S. B. Liggett, N. M. Tepe, J. N. Lorenz et al., “Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level,” Circulation, vol. 101, no. 14, pp. 1707–1714, 2000. View at Google Scholar
  40. X. J. Du, X. M. Gao, G. L. Jennings, A. M. Dart, and E. A. Woodcock, “Preserved ventricular contractility in infarcted mouse heart overexpressing β-adrenergic receptors,” American Journal of Physiology, vol. 279, no. 5, pp. H2455–H2463, 2000. View at Google Scholar · View at Scopus
  41. M. Iwase, S. P. Bishop, M. Uechi et al., “Adverse effects of chronic endogenous sympathetic drive induced by cardiac G overexpression,” Circulation Research, vol. 78, no. 4, pp. 517–524, 1996. View at Google Scholar · View at Scopus
  42. Y. J. Geng, Y. Ishikawa, D. E. Vatner et al., “Apoptosis of cardiac myocytes in Gsα transgenic mice,” Circulation Research, vol. 84, no. 1, pp. 34–42, 1999. View at Google Scholar · View at Scopus
  43. B. R. DeGeorge Jr., E. Gao, M. Boucher et al., “Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stress,” Circulation, vol. 117, no. 11, pp. 1378–1387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. D. G. Tilley and H. A. Rockman, “Role of β-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment,” Expert Review of Cardiovascular Therapy, vol. 4, no. 3, pp. 417–432, 2006. View at Publisher · View at Google Scholar
  45. W. Z. Zhu, S. Q. Wang, K. Chakir et al., “Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 617–625, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Yoo, A. Lemaire, S. Mangmool et al., “β1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction,” American Journal of Physiology, vol. 297, no. 4, pp. H1377–H1386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Zhu, A. Y. H. Woo, D. Yang, H. Cheng, M. T. Crow, and R. P. Xiao, “Activation of CaMKII is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis,” Journal of Biological Chemistry, vol. 282, no. 14, pp. 10833–10839, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Communal, W. S. Colucci, and K. Singh, “p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against β-adrenergic receptor-stimulated apoptosis. Evidence for G(i)-dependent activation,” Journal of Biological Chemistry, vol. 275, no. 25, pp. 19395–19400, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Remondino, S. H. Kwon, C. Communal et al., “β-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH-terminal kinase-dependent activation of the mitochondrial pathway,” Circulation Research, vol. 92, no. 2, pp. 136–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Ito, T. Adachi, D. R. Pimentel, Y. Ido, and W. S. Colucci, “Statins inhibit β-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism,” Circulation, vol. 110, no. 4, pp. 412–418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Menon, J. N. Johnson, R. S. Ross, M. Singh, and K. Singh, “Glycogen synthase kinase-3β plays a pro-apoptotic role in β-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: role of β1 integrins,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 3, pp. 653–661, 2007. View at Publisher · View at Google Scholar
  52. M. Singh, M. Roginskaya, S. Dalal et al., “Extracellular ubiquitin inhibits β-AR-stimulated apoptosis in cardiac myocytes: role of GSK-3β and mitochondrial pathways,” Cardiovascular Research, vol. 86, no. 1, pp. 20–28, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Zheng, S. J. Zhang, W. Z. Zhu, B. Ziman, B. K. Kobilka, and R. P. Xiao, “β-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by G or Gβγ in adult mouse cardiomyocytes,” Journal of Biological Chemistry, vol. 275, no. 51, pp. 40635–40640, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. P. S. Peter, J. E. Brady, L. Yan et al., “Inhibition of p38α MAPK rescues cardiomyopathy induced by overexpressed β-adrenergic receptor, but not β-adrenergic receptor,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1335–1343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. E. E. J. M. Creemers, J. P. M. Cleutjens, J. F. M. Smits, and M. J. A. P. Daemen, “Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?” Circulation Research, vol. 89, no. 3, pp. 201–210, 2001. View at Google Scholar · View at Scopus
  56. F. G. Spinale, M. L. Coker, B. R. Bond, and J. L. Zellner, “Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target,” Cardiovascular Research, vol. 46, no. 2, pp. 225–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. F. G. Spinale, “Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function,” Physiological Reviews, vol. 87, no. 4, pp. 1285–1342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. V. S. Mujumdar, L. M. Smiley, and S. C. Tyagi, “Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength,” International Journal of Cardiology, vol. 79, no. 2-3, pp. 277–286, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Y. Wang, M. R. Bergman, A. P. Nguyen et al., “Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility,” Cardiovascular Research, vol. 69, no. 3, pp. 688–696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Hayashidani, H. Tsutsui, M. Ikeuchi et al., “Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction,” American Journal of Physiology, vol. 285, no. 3, pp. H1229–H1235, 2003. View at Google Scholar · View at Scopus
  61. B. Menon, M. Singh, and K. Singh, “Matrix metalloproteinases mediate β-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes,” American Journal of Physiology, vol. 289, no. 1, pp. C168–C176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Menon, M. Singh, R. S. Ross, J. N. Johnson, and K. Singh, “β-adrenergic receptor-stimulated apoptosis in adult cardiac myocytes involves MMP-2-mediated disruption of β1 integrin signaling and mitochondrial pathway,” American Journal of Physiology, vol. 290, no. 1, pp. C254–C261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. L. Hicke, “Protein regulation by monoubiquitin,” Nature Reviews Molecular Cell Biology, vol. 2, no. 3, pp. 195–201, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. J. D. Schnell and L. Hicke, “Non-traditional functions of ubiquitin and ubiquitin-binding proteins,” Journal of Biological Chemistry, vol. 278, no. 38, pp. 35857–35860, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Sigismund, S. Polo, and P. P. Di Fiore, “Signaling through monoubiquitination,” Current Topics in Microbiology and Immunology, vol. 286, pp. 149–185, 2004. View at Google Scholar · View at Scopus
  66. F. G. Giancotti and E. Ruoslahti, “Integrin signaling,” Science, vol. 285, no. 5430, pp. 1028–1032, 1999. View at Publisher · View at Google Scholar · View at Scopus
  67. R. O. Hynes, “Integrins: a family of cell surface receptors,” Cell, vol. 48, no. 4, pp. 549–554, 1987. View at Google Scholar · View at Scopus
  68. M. J. Humphries, “Integrin structure,” Biochemical Society Transactions, vol. 28, no. 4, pp. 311–340, 2000. View at Google Scholar · View at Scopus
  69. R. O. Hynes, “Integrins: bidirectional, allosteric signaling machines,” Cell, vol. 110, no. 6, pp. 673–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. D. G. Stupack and D. A. Cheresh, “Get a ligand, get a life: integrins, signaling and cell survival,” Journal of Cell Science, vol. 115, no. 19, pp. 3729–3738, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. R. S. Ross and T. K. Borg, “Integrins and the myocardium,” Circulation Research, vol. 88, no. 11, pp. 1112–1119, 2001. View at Google Scholar · View at Scopus
  72. R. S. Ross, “Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors,” Cardiovascular Research, vol. 63, no. 3, pp. 381–390, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Imanaka-Yoshida, M. Enomoto-Iwamoto, T. Yoshida, and T. Sakakura, “Vinculin, talin, integrin α6β1 and laminin can serve as components of attachment complex mediating contraction force transmission from cardiomyocytes to extracellular matrix,” Cell Motility and the Cytoskeleton, vol. 42, no. 1, pp. 1–11, 1999. View at Publisher · View at Google Scholar · View at Scopus
  74. B. Ding, R. L. Price, E. C. Goldsmith et al., “Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure,” Circulation, vol. 101, no. 24, pp. 2854–2862, 2000. View at Google Scholar · View at Scopus
  75. J. L. Zellner, F. G. Spinale, D. M. Eble, K. W. Hewett, and F. A. Crawford, “Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure,” Circulation Research, vol. 69, no. 3, pp. 590–600, 1991. View at Google Scholar · View at Scopus
  76. S. M. Frisch and E. Ruoslahti, “Integrins and anoikis,” Current Opinion in Cell Biology, vol. 9, no. 5, pp. 701–706, 1997. View at Publisher · View at Google Scholar
  77. N. M. Hooper, E. H. Karran, and A. J. Turner, “Membrane protein secretases,” Biochemical Journal, vol. 321, no. 2, pp. 265–279, 1997. View at Google Scholar · View at Scopus
  78. J. J. Peschon, J. L. Slack, P. Reddy et al., “An essential role for ectodomain shedding in mammalian development,” Science, vol. 282, no. 5392, pp. 1281–1284, 1998. View at Google Scholar · View at Scopus
  79. A. M. Manso, L. Elsherif, S. M. Kang, and R. S. Ross, “Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling,” Cardiovascular Research, vol. 69, no. 3, pp. 574–584, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Menon, P. Krishnamurthy, E. Kaverina et al., “Expression of the cytoplasmic domain of β1 integrin induces apoptosis in adult rat ventricular myocytes (ARVM) via the involvement of caspase-8 and mitochondrial death pathway,” Basic Research in Cardiology, vol. 101, no. 6, pp. 485–493, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. N. I. Zhidkova, A. M. Belkin, and R. Mayne, “Novel isoform of β1 integrin expressed in skeletal and cardiac muscle,” Biochemical and Biophysical Research Communications, vol. 214, no. 1, pp. 279–285, 1995. View at Publisher · View at Google Scholar · View at Scopus
  82. A. M. Belkin, N. I. Zhidkova, F. Balzac et al., “β1D integrin displaces the β1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells,” Journal of Cell Biology, vol. 132, no. 1-2, pp. 211–226, 1996. View at Google Scholar · View at Scopus
  83. L. Terracio, K. Rubin, D. Gullberg et al., “Expression of collagen binding integrins during cardiac development and hypertrophy,” Circulation Research, vol. 68, no. 3, pp. 734–744, 1991. View at Google Scholar · View at Scopus
  84. R. S. Ross, C. Pham, S. Y. Shai et al., “β1 Integrins participate in the hypertrophic response of rat ventricular myocytes,” Circulation Research, vol. 82, no. 11, pp. 1160–1172, 1998. View at Google Scholar · View at Scopus
  85. C. G. Pham, A. E. Harpf, R. S. Keller et al., “Striated muscle-specific β(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway,” American Journal of Physiology, vol. 279, no. 6, pp. H2916–H2926, 2000. View at Google Scholar · View at Scopus
  86. E. Lara-Pezzi, C. M. N. Terracciano, G. K. R. Soppa et al., “A gene expression profile of the myocardial response to clenbuterol,” Journal of Cardiovascular Translational Research, vol. 2, no. 2, pp. 191–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Y. Shai, A. E. Harpf, C. J. Babbitt et al., “Cardiac myocyte-specific excision of the β1 integrin gene results in myocardial fibrosis and cardiac failure,” Circulation Research, vol. 90, no. 4, pp. 458–464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Communal, M. Singh, B. Menon, Z. Xie, W. S. Colucci, and K. Singh, “β1 integrins expression in adult rat ventricular myocytes and its role in the regulation of β-adrenergic receptor-stimulated apoptosis,” Journal of Cellular Biochemistry, vol. 89, no. 2, pp. 381–388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. P. Krishnamurthy, V. Subramanian, M. Singh, and K. Singh, “Deficiency of β1 integrins results in increased myocardial dysfunction after myocardial infarction,” Heart, vol. 92, no. 9, pp. 1309–1315, 2006. View at Publisher · View at Google Scholar
  90. L. Elsherif, M. S. Huang, S. Y. Shai et al., “Combined deficiency of dystrophin and β1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification,” Circulation Research, vol. 102, no. 9, pp. 1109–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. M. A. Wozniak, K. Modzelewska, L. Kwong, and P. J. Keely, “Focal adhesion regulation of cell behavior,” Biochimica et Biophysica Acta, vol. 1692, no. 2-3, pp. 103–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. M. G. Coppolino and S. Dedhar, “Bi-directional signal transduction by integrin receptors,” International Journal of Biochemistry and Cell Biology, vol. 32, no. 2, pp. 171–188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Brancaccio, E. Hirsch, A. Notte, G. Selvetella, G. Lembo, and G. Tarone, “Integrin signalling: the tug-of-war in heart hypertrophy,” Cardiovascular Research, vol. 70, no. 3, pp. 422–433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. S. E. Hardt and J. Sadoshima, “Glycogen synthase kinase-3β. A novel regulator of cardiac hypertrophy and development,” Circulation Research, vol. 90, no. 10, pp. 1055–1063, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Sabri, K. Rafiq, R. Seqqat, M. A. Kolpakov, R. Dillon, and L. J. Dell'italia, “Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog,” Circulation Research, vol. 102, no. 9, pp. 1127–1136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. G. Wang, X. Ji, M. Pabbidi, A. M. Samarel, and S. L. Lipsius, “Laminin acts via focal adhesion kinase/phosphatidylinositol-3 kinase/protein kinase B to down-regulate β-adrenergic receptor signalling in cat atrial myocytes,” Journal of Physiology, vol. 587, no. 3, pp. 541–550, 2009. View at Publisher · View at Google Scholar · View at Scopus